erythroleukemia


Also found in: Medical, Wikipedia.

erythroleukemia

a malignancy of the blood characterized by abnormally productive bone marrow and the development of oddly-shaped blood cells.
See also: Cancer
Translations

e·ryth·ro·leu·ke·mi·a

n. eritroleucemia, enfermedad sanguínea maligna caracterizada por el crecimiento anormal de glóbulos rojos y blancos.
Mentioned in ?
References in periodicals archive ?
Functional studies of P-glycoprotein in insideout plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3.
Effects of trichostatins on differentiation of murine erythroleukemia cells.
Age <21 21-40 41-60 >60 AML type Years Years Years Years Undifferentiated, % 91 89 74 51 Myeloblastic, % 80 83 62 48 Promyelocytic, % 85 79 68 39 Myelomonocytic, % 51 48 39 34 Monocytic, % 82 68 40 28 Erythroleukemia, % 73 61 37 21 Microkaryoblastic, % 62 57 31 16 Megakaryoblastic, % 52 41 24 9 Table 8.
This is quite important in the diagnosis of acute erythroleukemia.
NF-E2 was purified from mouse erythroleukemia (MEL) cells and is composed of 45 kDa and 18 kDa subunit (14).
S5 RNA expression also changes in differentiation and cell death (apoptosis) of murine erythroleukemia cells (Vizirianakis et al.
Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
In mouse erythroleukemia and fibroblast cells, inhibition of fos and jun has demonstrated their requirement for proliferation and cell-cycle progression (Shanlian and Karin 2001).
We have successfully purified ValRS-EF1H complex from K562 human erythroleukemia cells to near homogeneity.
Moreover, the retroviral particles generated in this manner can be used to transduce target cells, namely NIH-3T3 and murine erythroleukemia cells (MEL) as shown by PCR.